Exchange: NASDAQ·Updated 04:28 PM EST

WVE Earnings

Latest Earnings Results: Q3 '26

Reported: Oct 27

Estimated EPS

-$0.33

Reported EPS

-$0.30

Surprise

+8.83%

Estimated Rev

$4.51M

Reported Rev

$13.16M

Surprise

+191.6%

• Reported GAAP EPS of -$0.30 up 6.25% YoY • Reported revenue of $13.16M up 72.93% YoY • Wave Life Sciences expects current cash, cash equivalents, and marketable securities to fund operations into 3Q 2028; a $12M GSK milestone is expected in 4Q 2026 and is excluded from runway.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.32
--
--
N/A
Q3 '26
-$0.33
-$0.30
8.83%
BEAT
Q2 '26
-$0.30
-$0.34
-12.41%
MISSED
Q1 '26
-$0.32
-$0.13
59.82%
BEAT
Q4 '25
-$0.27
-$0.30
-9.56%
MISSED

Advertisement|Remove ads.